MAY 19, 2017 5:16 PM PDT

C. auris Superbug Seen in More Patients Across US

WRITTEN BY: Carmen Leitch

The Centers for Disease Control (CDC) issued an alert in June 2016 about Candida auris; later that summer seven cases were described. The CDC has now reported 122 new cases of infection resulting from the C. auris bacterium. It’s considered a superbug because it’s very difficult to treat, and is primarily a threat to those faced with lengthy hospital stays.

 

The infections are typically occurring in older, chronically ill people in healthcare facilities and the CDC is focusing efforts on preventing transmission there. The infections have happened in three principle areas: Illinois, New Jersey and New York.

C. auris was first identified in Japan, and has managed to spread around the world in only about eight years. Scientists are concerned about it not only because it is often resistant to so many drugs like fluconazole, amphotericin B, and even echinocandins; it also has a very high mortality rate.

“This emerging fungal species has started to infect patients globally, causing invasive infections that are associated with a high death rate,” commented Mahmoud Ghannoum, PhD, MBA, FIDSA, Professor and Director of the Center for Medical Mycology at the Department of Dermatology at Case Western Reserve School of Medicine, and University Hospitals Cleveland Medical Center. “It is multidrug-resistant, and some strains isolated from patients are resistant to all commercially available antifungal drugs. Multidrug-resistance used to be reported for bacteria only, and now we must add fungi to the list.”

Related: Understanding the Dissemination of Antibiotic Resistance Genes

Ghannoum has led a study of 16 strains of C. auris, and is studying the effects of an investigational drug on the infection.

“Understanding the virulence of C. auris and showing that the investigational drug is effective may lead to the development of new medications to combat this emerging health threat,” said Ghannoum. “Eradication of Candida auris from hospitals is very difficult and in some cases has led to closing hospital wards.”

The fungi lurk on catheters, and those staying in the hospital for long periods of time are most at risk.


Sources: STAT News, Case Western Reserve University, CDC, Medscape

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 16, 2020
Microbiology
Newly Discovered Gut Enzyme Could Function as Disease Biomarker
AUG 16, 2020
Newly Discovered Gut Enzyme Could Function as Disease Biomarker
Bacteria in the gut have a powerful influence on our health, in part because all of those microbes have genes of their o ...
SEP 28, 2020
Microbiology
The Flu Vaccine Will Not Increase the Risk of COVID-19
SEP 28, 2020
The Flu Vaccine Will Not Increase the Risk of COVID-19
Scientists and clinicians want people to get their flu shots this year, especially because of the ongoing pandemic.
OCT 01, 2020
Microbiology
Investigating the Origins of a Cholera Epidemic
OCT 01, 2020
Investigating the Origins of a Cholera Epidemic
Cholera is an intestinal infection caused by Vibrio cholerae. Cholera has been a scourge throughout human history, and i ...
OCT 15, 2020
Microbiology
WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections
OCT 15, 2020
WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections
While the study has not yet been peer-reviewed, an International consortium including researchers has come to the conclu ...
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...